E Mintzer J, F Mirski D, S Hoernig K Behavioral and psychological signs and symptoms of dementia: a practicing psychiatrist's viewpoint. Dialogues Clin Neurosci. 2000 Jun;2(2):139-55.
Floyd M, Scogin F Effects of memory training on the subjective memory functioning and mental health of older adults: a meta-analysis. Psychol Aging. 1997 Mar;12(1):150-61.
Jean L, Bergeron ME, Thivierge S, Simard M Cognitive intervention programs for individuals with mild cognitive impairment: systematic review of the literature. Am J Geriatr Psychiatry. 2010 Apr;18(4):281-96. doi: 10.1097/JGP.0b013e3181c37ce9. Review.
Neely AS, Bäckman L Effects of multifactorial memory training in old age: generalizability across tasks and individuals. J Gerontol B Psychol Sci Soc Sci. 1995 May;50(3):P134-40.
Novoa AM, Juárez O, Nebot M [Review of the effectiveness of cognitive interventions in preventing cognitive deterioration in healthy elderly individuals]. Gac Sanit. 2008 Sep-Oct;22(5):474-82. Review. Spanish.
Rey Cao A, Canales Lacruz I, Táboas Pais MI [Quality of life perceived by the elderly. Results of the "Memory in movement" program which provide cognitive stimulation using motricity]. Rev Esp Geriatr Gerontol. 2011 Mar-Apr;46(2):74-80. doi: 10.1016/j.re
Valdizán JR [Cognitive functions and neuronal networks in the social brain]. Rev Neurol. 2008;46 Suppl 1:S65-8. Review. Spanish.
Wilkinson AJ, Yang L Long-Term Maintenance of Inhibition Training Effects in Older Adults: 1- and 3-Year Follow-Up. J Gerontol B Psychol Sci Soc Sci. 2016 Jul;71(4):622-9. doi: 10.1093/geronb/gbu179. Epub 2015 Jan 7.
Effectiveness of Two Predefined Groups With Cognitive Rehabilitation in Older Adults With the Program Neuron-up
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
